Free Trial

Kindly MD (KDLY) Competitors

Kindly MD logo
$10.97 +0.07 (+0.64%)
As of 07/25/2025

KDLY vs. TOI, VMD, XGN, DCGO, EUDA, SERA, CORBF, QIPT, NAKA, and ATPC

Should you be buying Kindly MD stock or one of its competitors? The main competitors of Kindly MD include Oncology Institute (TOI), Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), EUDA Health (EUDA), Sera Prognostics (SERA), Global Cord Blood (CORBF), Quipt Home Medical (QIPT), KindlyMD (NAKA), and Agape ATP (ATPC). These companies are all part of the "healthcare" industry.

Kindly MD vs. Its Competitors

Oncology Institute (NASDAQ:TOI) and Kindly MD (NASDAQ:KDLY) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

Kindly MD has lower revenue, but higher earnings than Oncology Institute. Kindly MD is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oncology Institute$393.41M0.83-$64.66M-$0.70-5.26
Kindly MD$2.47M26.74-$4.64M-$0.77-14.25

Kindly MD has a net margin of 0.00% compared to Oncology Institute's net margin of -15.38%. Kindly MD's return on equity of 0.00% beat Oncology Institute's return on equity.

Company Net Margins Return on Equity Return on Assets
Oncology Institute-15.38% -445.02% -34.13%
Kindly MD N/A N/A N/A

Oncology Institute currently has a consensus target price of $7.00, suggesting a potential upside of 90.22%. Given Oncology Institute's stronger consensus rating and higher probable upside, analysts plainly believe Oncology Institute is more favorable than Kindly MD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oncology Institute
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
Kindly MD
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

36.9% of Oncology Institute shares are owned by institutional investors. 8.5% of Oncology Institute shares are owned by company insiders. Comparatively, 50.5% of Kindly MD shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Oncology Institute had 6 more articles in the media than Kindly MD. MarketBeat recorded 6 mentions for Oncology Institute and 0 mentions for Kindly MD. Oncology Institute's average media sentiment score of 0.73 beat Kindly MD's score of 0.00 indicating that Oncology Institute is being referred to more favorably in the media.

Company Overall Sentiment
Oncology Institute Positive
Kindly MD Neutral

Summary

Oncology Institute beats Kindly MD on 10 of the 16 factors compared between the two stocks.

Get Kindly MD News Delivered to You Automatically

Sign up to receive the latest news and ratings for KDLY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KDLY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KDLY vs. The Competition

MetricKindly MDHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$66.06M$88.96M$5.69B$9.50B
Dividend YieldN/AN/A4.58%4.01%
P/E Ratio-14.25N/A28.2320.08
Price / Sales26.749.70430.5089.23
Price / CashN/A4.0236.2258.56
Price / BookN/A1.158.665.88
Net Income-$4.64M-$26.33M$3.25B$258.72M
7 Day Performance-0.45%-0.23%4.24%3.72%
1 Month Performance-22.31%-11.15%10.51%11.73%
1 Year Performance509.48%509.48%34.43%18.02%

Kindly MD Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KDLY
Kindly MD
N/A$10.97
+0.6%
N/A+453.3%$66.06M$2.47M-14.25N/A
TOI
Oncology Institute
2.1083 of 5 stars
$3.21
+2.6%
$7.00
+118.1%
+593.2%$286.44M$403.15M-4.59660Analyst Forecast
Analyst Revision
High Trading Volume
VMD
Viemed Healthcare
1.8833 of 5 stars
$6.72
-0.3%
N/A-19.2%$265.57M$224.26M22.401,179Positive News
XGN
Exagen
4.1838 of 5 stars
$7.07
+1.1%
$7.50
+6.1%
+258.1%$150.59M$56.72M-8.42220News Coverage
Upcoming Earnings
Analyst Forecast
High Trading Volume
DCGO
DocGo
2.059 of 5 stars
$1.46
-2.0%
$3.56
+143.8%
-58.9%$148.90M$520.50M-73.004,407News Coverage
Positive News
EUDA
EUDA Health
0.9096 of 5 stars
$3.29
-0.3%
N/A-17.8%$122.24M$4.01M0.002Positive News
Upcoming Earnings
SERA
Sera Prognostics
0.7331 of 5 stars
$2.76
-2.8%
N/A-59.5%$103.98M$115K-2.94120
CORBF
Global Cord Blood
N/A$0.75
flat
N/A-47.4%$91.16M$196.12M0.001,200Gap Up
QIPT
Quipt Home Medical
2.9946 of 5 stars
$1.90
+1.6%
$2.85
+50.0%
-40.7%$82.54M$240.85M-9.051,200
NAKA
KindlyMD
N/A$12.09
-1.7%
N/AN/A$72.90M$2.47M-15.70N/A
ATPC
Agape ATP
0.8711 of 5 stars
$1.38
-7.6%
N/A-40.8%$68.76M$1.29M-2.2940Positive News

Related Companies and Tools


This page (NASDAQ:KDLY) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners